Potential of NOTCH1 Mutation to Predict Anti-PD1 Treatment Outcomes in Patients with Oesophageal Squamous Cell Cancer By Ogkologos - April 23, 2025 781 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a biomarker analysis from the RATIONALE-302 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Adjusting to the Challenges of Life After Cancer: An Expert Perspective May 5, 2022 Having a Heart Attack May Make Breast Cancer Grow Faster August 17, 2020 Study Details Long-Term Side Effects of Immune Checkpoint Inhibitors April 30, 2021 Cancer in My Community: Accessing Care Through the Public Health System... May 9, 2023 Load more HOT NEWS An Abnormal Baseline Geriatric 8 Screening Tool Score Strongly Associates with... Can Using Hair Dyes or Hair Relaxers Impact Your Cancer Risk? Insulin Resistance May Contribute to Poorer Breast Cancer Outcomes, Study Says Selpercatinib Approved for Thyroid and Lung Cancers with RET Gene Alterations
